-+ 0.00%
-+ 0.00%
-+ 0.00%

ONWARD THERAPEUTICS CLOSES NT$900 MILLION (APPROXIMATELY US$28 MILLION) SERIES B FINANCING TO ADVANCE CLINICAL-STAGE ONCOLOGY PIPELINE

Reuters·11/17/2026 23:00:16

Please log in to view news